Computational and Conformational Evaluation of FTase Alternative Substrates: Insight into a Novel Enzyme Binding Pocket

Protein farnesyltransferase (FTase) is an important anticancer drug target. In an effort to develop isoprenoid diphosphate-based FTase inhibitors, striking variations have been observed in the ability of conservatively modified analogues to bind to the enzyme. For example, 2Z-GGPP is an alternative substrate with high binding affinity, while GGPP is not an alternative substrate. Using the availability of high-resolution FTase crystal structures, we have used pharmacophore and docking studies to elucidate a new binding pocket for isoprenoid analogues. The unique conformations between the first two isoprene units of 2Z-GGPP, but not GGPP, allows 2Z-GGPP to exploit this new binding pocket. The discovered conformation allows the molecule to adopt a reactive conformation while placing hydrophobic groups within the predominately hydrophobic binding pocket. This computational finding is supported by NMR studies on (13)C-labeled 2Z-farnesol, which confirm that the computationally predicted conformation is also favored in solution. These discoveries suggest that ligand conformational flexibility may be an important design consideration for the development of both inhibitors and alternative substrates of FTase.

[1]  W. L. Jorgensen,et al.  Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids , 1996 .

[2]  J. Gasteiger,et al.  ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES , 1980 .

[3]  D. E. Clark,et al.  Flexible docking using tabu search and an empirical estimate of binding affinity , 1998, Proteins.

[4]  R. Gibbs,et al.  Stereospecific synthesis and biological evaluation of farnesyl diphosphate isomers. , 1999, Organic letters.

[5]  Thomas A. Halgren.  Merck molecular force field. III. Molecular geometries and vibrational frequencies for MMFF94 , 1996, J. Comput. Chem..

[6]  R. Gibbs,et al.  Evaluation of Isoprenoid Conformation in Solution and in the Active Site of Protein-Farnesyl Transferase Using Carbon-13 Labeling in Conjunction with Solution- and Solid-State NMR , 2000 .

[7]  Alexander D. MacKerell,et al.  All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.

[8]  T. Halgren,et al.  Merck molecular force field. V. Extension of MMFF94 using experimental data, additional computational data, and empirical rules , 1996 .

[9]  R. Isaacs,et al.  Protein farnesyltransferase isoprenoid substrate discrimination is dependent on isoprene double bonds and branched methyl groups. , 2001, Biochemistry.

[10]  C. Fierke,et al.  Photoaffinity analogues of farnesyl pyrophosphate transferable by protein farnesyl transferase. , 2002, Journal of the American Chemical Society.

[11]  R. Muschel,et al.  Farnesyltransferase inhibitors: an overview of the results of preclinical and clinical investigations. , 2003, Cancer research.

[12]  P. Casey,et al.  Evidence for a Catalytic Role of Zinc in Protein Farnesyltransferase , 1997, The Journal of Biological Chemistry.

[13]  M. Karplus,et al.  CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .

[14]  R. Gibbs,et al.  Novel farnesol and geranylgeraniol analogues: A potential new class of anticancer agents directed against protein prenylation. , 1999, Journal of medicinal chemistry.

[15]  R. Gibbs,et al.  Synthesis and evaluation of GGPP geometric isomers: divergent substrate specificities of FTase and GGTase I. , 2001, Bioorganic & medicinal chemistry letters.

[16]  Stephen B. Long,et al.  Reaction path of protein farnesyltransferase at atomic resolution , 2002, Nature.

[17]  Sebastian Maurer-Stroh,et al.  Protein prenyltransferases , 2003, Genome Biology.

[18]  T. Halgren.  Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94 , 1996, J. Comput. Chem..

[19]  Inhibitors of farnesyltransferase: a rational approach to cancer chemotherapy? , 2004, Journal of medicinal chemistry.

[20]  William L. Jorgensen,et al.  OPLS all‐atom force field for carbohydrates , 1997 .

[21]  E. W. Della,et al.  Spin-Spin Coupling Constants Between Carbons Separated by More Than One Bond , 1992 .

[22]  P. Casey,et al.  Cocrystal structure of protein farnesyltransferase complexed with a farnesyl diphosphate substrate. , 1998, Biochemistry.

[23]  R. Gibbs,et al.  Non-peptidic prenyltransferase inhibitors: diverse structural classes and surprising anti-cancer mechanisms. , 2001, Current medicinal chemistry.

[24]  Thomas A. Halgren,et al.  Merck molecular force field. II. MMFF94 van der Waals and electrostatic parameters for intermolecular. interactions , 1996, J. Comput. Chem..

[25]  D. Ferguson,et al.  A new approach to probing conformational space with molecular mechanics: Random incremental pulse search , 1989 .

[26]  M. Distefano,et al.  Biochemical and structural studies with prenyl diphosphate analogues provide insights into isoprenoid recognition by protein farnesyl transferase. , 2003, Biochemistry.

[27]  J. L. Marshall.  Carbon-Carbon and Carbon-Proton Nmr Couplings: Applications to Organic Stereochemistry and Conformational Analysis , 1983 .

[28]  Thomas A. Halgren,et al.  Merck molecular force field. IV. conformational energies and geometries for MMFF94 , 1996, J. Comput. Chem..

[29]  P. Casey,et al.  The basis for K-Ras4B binding specificity to protein farnesyltransferase revealed by 2 A resolution ternary complex structures. , 2000, Structure.